Expand CRSP Menu
CRSP MENU

CRSP Latest Press Releases

-- March 11, 2026 --

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering Globe Newswire 7:00 AM

-- March 10, 2026 --

CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering Globe Newswire 7:00 AM

-- February 12, 2026 --

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 4:30 PM

-- January 28, 2026 --

Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine Globe Newswire 8:05 AM

-- January 12, 2026 --

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones Globe Newswire 8:36 AM

-- January 5, 2026 --

CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:30 AM

-- December 16, 2025 --

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes Globe Newswire 12:00 PM

-- December 9, 2025 --

Beyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat Conditions PRNewswire 11:58 AM

-- November 19, 2025 --

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care Globe Newswire 10:06 AM

-- November 10, 2025 --

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results Globe Newswire 8:00 AM

-- November 8, 2025 --

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310 Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering Globe Newswire 9:56 AM
Market Data Delayed 15 Minutes